Evidence map›Paper›PMID 42332802›Full record

ArticleBiological research2026

Impact of Salvadora persica aqueous extract on follicular development in female rats.

Sabreen M Ghareeb, Mahmoud Abd-Elkareem, Ahmed Abou-Elmagd

Abstract read
In one paragraph

Article in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sabreen M GhareebDepartment of Cell and Tissues, Faculty of Veterinary Medicine, Assiut University, Assiut, 71526, Egypt.
Mahmoud Abd-ElkareemDepartment of Cell and Tissues, Faculty of Veterinary Medicine, Assiut University, Assiut, 71526, Egypt. mahmoud.mahmoud3@vet.aun.edu.eg.ORCID http://orcid.org/0000-0003-3715-011X
Ahmed Abou-ElmagdDepartment of Cell and Tissues, Faculty of Veterinary Medicine, Assiut University, Assiut, 71526, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvadora persica (miswak) has many useful biological activities. Some studies have reported that miswak can be used as a contraceptive agent. However, no available investigations explain the histomorphological structure of ovarian follicles after miswak aqueous extract (MAE) administration. Twelve female Wistar albino rats were divided into two equal groups. In the control group (CG), the animals received normal saline daily for 4 weeks. While in the miswak treated group (MTG), the animals received orally 900 mg/kg of body weight of the MAE daily for the same period. At the end of the experiment, the rats were anesthetized and then euthanized by cervical dislocation. The ovaries were dissected, removed, weighted, fixed, and processed for histological examination by light and electron microscopy.Results revealed that the ovaries of CG showed various stages of follicular development. While in the MTG, the ovaries exhibited follicular atresia. The immunoexpression of caspase-3, progesterone receptors (PR), and estrogen receptors alpha (ERA) in the MTG and CG were reported.Our preliminary animal research indicates that MAE can inhibit follicular development and induce follicular atresia. These findings suggest a potential antifollicular and/or antiovulatory effect that requires confirmation through dose-response, fertility, toxicity, and clinical studies.

Indexed as

Follicular AtresiaOvarian FolliclePlant ExtractsSalvadoraceaeAnimalsCaspase 3FemaleImmunohistochemistryRatsRats, WistarReceptors, ProgesteroneCaspase 3Plant ExtractsReceptors, ProgesteroneAtresiaFolliclesMiswak (Salvadora persica)OvaryRats

Identifiers

PMID42332802
PMCPMC13285512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.